Environmental

R&D intensity near 10.4% of revenue suggests a moderate innovation footprint, but peers in medtech often show similar development spending, limiting relative differentiation.

No direct emissions, energy, or waste disclosures were provided, so environmental positioning cannot be credited above peers with clearer operational sustainability reporting.

High gross margin indicates a less resource-intensive product mix, yet this is only an indirect environmental signal and weaker than peer-specific climate metrics.

Absent evidence of material environmental controversies, XERS appears broadly in line with peers, but disclosure depth remains insufficient for a stronger score.

Social

R&D spending supports product development and patient-focused innovation, but peer comparison remains constrained because no clinical safety or access metrics were provided.

Stock-based compensation at 8.4% of revenue can align employees with long-term execution, though it may also dilute stakeholder alignment versus better-disciplined peers.

No workforce, diversity, or supply-chain labor disclosures were provided, leaving social risk assessment dependent on limited proxy metrics rather than direct evidence.

Overall social positioning appears average versus medtech peers because available metrics show commitment to innovation, but not clearly superior stakeholder outcomes.

Governance

Stock-based compensation at 8.4% of revenue suggests meaningful equity dilution pressure, which can weaken governance discipline versus peers with tighter compensation control.

The negative debt-to-equity ratio likely reflects balance-sheet distortions rather than strong capital structure clarity, reducing confidence relative to peers with cleaner disclosures.

Net debt to EBITDA above 10x indicates limited financial flexibility, which can heighten governance scrutiny around capital allocation and risk oversight versus peers.

No board, audit, or shareholder-rights data were provided, so governance assessment remains moderate and anchored mainly by compensation and leverage signals.

Overall Score

XERS appears broadly in line with peers on ESG, but limited disclosure and mixed governance signals prevent a stronger relative positioning score.

Score Driver: Governance Is Constrained By Dilution And Leverage Signals, Offsetting Otherwise Neutral-To-Average ESG Indicators.